GLP-1 agonists, like Ozempic and Wegovy, promise easy weight loss. But the outlandish side effects are stacking up. The latest? Bad breath, dry mouth, inflammation and tooth decay. Here’s why, and how users can lessen the threat to their oral health…

While GLP-1 drugs like Ozempic and Wegovy are having their moment, we’re learning they can lead to intestinal damage and the possibility of “life-long treatment” to keep weight from returning. Why risk it when researchers say another evidence-based strategy is safer and works?